NIT
BLCM

NumerixS Investment Technologies’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

NumerixS Investment Technologies’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-180
Closed -$21K – 1409
2017
Q3 		$21K Sell
180
-3,100
-95% -$326K ﹤0.01% 1047
2017
Q2 		$383K Buy
+3,280
New +$407K 0.06% 414
2017
Q1 		– Sell
-500
Closed -$68K – 1433
2016
Q4 		$68K Buy
+500
New +$88.8K 0.01% 926

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NumerixS Investment Technologies's BLCM Position: Q4 2017 in Review

NumerixS Investment Technologies sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2017, closing a stake of 180 shares — an estimated $21K sold.

NumerixS Investment Technologies first reported a position in BLCM in Q4 2016 and held it in 3 quarters. The position peaked at $383K in Q2 2017. 91 funds tracked by Wall St. Rank hold BLCM as of Q4 2017.

  • NumerixS Investment Technologies reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • NumerixS Investment Technologies sold 180 Bellicum Pharmaceuticals, Inc. shares in Q4 2017, an estimated $21K.
  • NumerixS Investment Technologies first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2016 and held it in 3 quarters.
  • NumerixS Investment Technologies's Bellicum Pharmaceuticals, Inc. position peaked at $383K in Q2 2017.
  • 91 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2017.

Based on NumerixS Investment Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.